Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research
FREMONT, Calif., Jan. 13, 2026 /PRNewswire/ — Alamar Biosciences, Inc. (“Alamar”), a pacesetter in precision proteomics devoted to advancing the ...














)